BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1839991)

  • 1. CD4+ TCR alpha beta+ T-cells developing after allogeneic bone marrow transplantation in patients with chronic myelogenous leukaemia. Dipyridamole inhibits functionally heterogeneous T-cell clones.
    Bruserud O; Hamann W; Patel S; Pawelec G
    Int J Immunopharmacol; 1991; 13(8):1127-35. PubMed ID: 1839991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ TCR alpha beta+ T-cell clones derived shortly after allogeneic bone marrow transplantation: theophyllamine and verapamil inhibit proliferation of functionally heterogeneous T-cells.
    Bruserud O; Hamann W; Patel S; Pawelec G
    Int J Immunopharmacol; 1992 Jul; 14(5):783-9. PubMed ID: 1387389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL2- and IL4-dependent proliferation of T-cell clones derived early after allogeneic bone marrow transplantation: studies of patients with chronic myelogenous leukaemia.
    Bruserud O; Hamann W; Patel S; Ehninger G; Pawelec G
    Eur J Haematol; 1992 Apr; 48(4):221-7. PubMed ID: 1350537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of IL-2, IL-3, IL-4, IL-6 and GM-CSF by CD4+ and CD8+ TCR alpha beta+ T-cell clones derived early after allogeneic bone marrow transplantation.
    Bruserud O; Ehninger G; Hamann W; Pawelec G
    Scand J Immunol; 1993 Jul; 38(1):65-74. PubMed ID: 8327861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic and proliferative functions of T lymphocyte clones derived very shortly after allogeneic bone marrow transplantation.
    Hamann W; Bruserud O; Patel S; Schmidt H; Ehninger G; Pawelec G
    Bone Marrow Transplant; 1991 Aug; 8(2):113-8. PubMed ID: 1933051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of leukaemia inhibitory factor after allogeneic bone marrow transplantation: a study of CD4+ and CD8+ TCR alpha beta+ T-cell clones derived from four leukaemia patients.
    Bruserud O; Hamann W; Pawelec G
    Eur J Haematol; 1995 Feb; 54(2):106-10. PubMed ID: 7698292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts; studies of normal polyclonal T cells and T lymphocyte clones derived early after allogenic bone marrow transplantation.
    Bruserud O; Pawelec G
    Cancer Immunol Immunother; 1996 Mar; 42(3):133-40. PubMed ID: 8640841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4.
    van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE
    J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease.
    Jiang YZ; Mavroudis DA; Dermime S; Molldrem J; Hensel NF; Barrett AJ
    Bone Marrow Transplant; 1997 May; 19(9):899-903. PubMed ID: 9156263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
    Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
    J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-13 secretion by normal and posttransplant T lymphocytes; in vitro studies of cellular immune responses in the presence of acute leukaemia blast cells.
    Bruserud O; Pawelec G
    Cancer Immunol Immunother; 1997 Oct; 45(1):45-52. PubMed ID: 9353426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma and TNF-alpha secretion by CD4+ and CD8+ TCR alpha beta + T-cell clones derived early after allogeneic bone marrow transplantation.
    Bruserud O; Hamann W; Patel S; Ehninger G; Schmidt H; Pawelec G
    Eur J Haematol; 1993 Aug; 51(2):73-9. PubMed ID: 8370421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD4+ T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cells.
    Zorn E; Orsini E; Wu CJ; Stein B; Chillemi A; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Transplantation; 2001 Apr; 71(8):1131-7. PubMed ID: 11374415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine A and FK506 show similar immunosuppressive effects on long-term in vitro T-cell proliferation.
    Bruserud O; Pawelec G
    Int J Immunopharmacol; 1993 Feb; 15(2):93-7. PubMed ID: 7682202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4.
    Paliard X; Yssel H; Blanchard D; Waitz JA; deVries JE; Spits H
    J Immunol; 1989 Jul; 143(2):452-7. PubMed ID: 2472439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic and noncytotoxic mechanisms involved in the in vitro anti-leukaemia effects of T cell clones established from a chronic myelogenous leukaemia patient during treatment in vivo with interferon alpha.
    Pawelec G; Reutter M; Owsianowsky M; Rehbein A; Busch FW
    Cancer Immunol Immunother; 1991; 33(1):54-60. PubMed ID: 1902397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
    Wang P; Vánky F; Klein E
    Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.